What effect does a dose of 5 µg/kg/min of dobutamine have in a 2‑year‑old child weighing approximately 12 kg?

Dobutamine 5 µg/kg/min in a 2-Year-Old Child: Expected Effects

At 5 µg/kg/min, dobutamine will produce moderate inotropic effects with increased cardiac output and improved myocardial contractility, while causing minimal changes in heart rate and blood pressure in this 2-year-old child.

Cardiovascular Effects at This Dose

This dose falls within the standard therapeutic range and will produce the following effects:

Primary Inotropic Effects

• Increased cardiac output: The dose of 5 µg/kg/min sits in the middle of the typical dosing range (2-20 µg/kg/min) and produces measurable improvements in cardiac contractility 1
• Enhanced myocardial contractility: Research in healthy children demonstrates that dobutamine improves systolic function even at plasma concentrations achieved with infusion rates as low as 1-2 µg/kg/min, with the 5 µg/kg/min dose producing clear inotropic effects 2
• Improved diastolic function: Beyond systolic enhancement, this dose also improves ventricular relaxation and filling 2

Hemodynamic Parameters

• Heart rate: At 5 µg/kg/min, expect minimal to modest increases in heart rate. Studies in children show that chronotropic effects typically occur at higher plasma concentrations than other hemodynamic effects 2. In infants with ventricular septal defects, this dose produced only modest heart rate increases 3
• Blood pressure: Expect modest increases in systolic and mean arterial pressure, though changes may be minimal 3, 4
• Afterload reduction: Dobutamine at this dose reduces systemic vascular resistance through β2-adrenergic effects 2

Pediatric-Specific Considerations

Age-Related Response

Critical caveat: The 2009 American College of Critical Care Medicine guidelines specifically note that children <12 months may be less responsive to dobutamine 5. However, at 2 years of age, this child is beyond this vulnerable period and should demonstrate typical responsiveness.

Dosing Context

• The FDA label indicates that infusion should start at 0.5-1.0 µg/kg/min and be titrated based on response 1
• 5 µg/kg/min represents a mid-range therapeutic dose that is commonly effective without reaching the upper limits where adverse effects become more likely
• The optimal infusion rate varies between patients, typically ranging 2-20 µg/kg/min 1

Clinical Monitoring Requirements

When administering this dose, monitor:

• Systemic blood pressure
• Heart rate (watch for excessive tachycardia)
• Urine output
• Frequency of ectopic cardiac activity
• Cardiac output measurements when possible 1

Safety Profile at This Dose

The 5 µg/kg/min dose is generally well-tolerated in children, though vigilance is required:

• Arrhythmia risk: While dobutamine can cause tachycardia and arrhythmias, these effects are more pronounced at higher doses. Studies show that at 5 µg/kg/min in children, significant arrhythmias are uncommon 6
• Hypotension: Rare at this dose level, occurring in approximately 5% of patients in recent studies 7
• Pharmacokinetic variability: Dobutamine clearance in children shows >5-fold intersubject variability (mean 115 ± 63 mL/kg/min), meaning plasma concentrations and responses can vary significantly even at the same dose 2

Practical Application

For this 12 kg child receiving 5 µg/kg/min:

• Total dose = 60 µg/min = 3.6 mg/hour
• Using standard 1000 µg/mL concentration: infusion rate = 3.6 mL/hour 1

The dose should be titrated based on clinical response rather than adhering rigidly to a fixed rate, as the 2009 pediatric septic shock guidelines emphasize that vasoactive agents represent a dynamic process requiring adjustment over time 5.